Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Antiviral Agents. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113461648A discloses a streamlined 2-step synthesis for coumarin-based neuraminidase inhibitors, offering a cost-effective alternative to complex antiviral routes.
Novel one-pot synthesis of piperazinone-hydroxypyridone-5-carboxyl compounds via metal-free catalysis. Enhances supply chain reliability and reduces manufacturing costs for RNA polymerase inhibitors.
Patent CN114133364B reveals a green synthesis for oseltamivir intermediates using biphasic catalysis, offering high purity and reduced manufacturing costs for global supply chains.
Novel patent CN106554371A offers low-cost TNF preparation. Enhances supply chain reliability and purity for pharmaceutical intermediates manufacturing processes globally.
Patent CN101857613A reveals a novel PTC synthesis for anti-influenza rupestonic acid esters, offering cost reduction in API manufacturing and scalable production.
Patent CN111320598A reveals a cost-effective synthesis of 3-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one, offering superior purity and scalability for antiviral API production.
Novel two-step route for Remdesivir intermediate CN111205294A. Enhanced chiral purity, reduced cost, scalable manufacturing for global pharma supply chains.
Advanced purification method for 2'-fluoro-2'-deoxyuridine via esterification. Delivers >98.5% purity for reliable pharmaceutical intermediate supply chains.
Patent CN1277807C details a novel metal hydride reduction route for carbocyclic nucleoside intermediates, offering significant cost reduction and scalable manufacturing capabilities.
Patent CN111484528A reveals a novel halogenation route for TAF intermediates, offering superior purity and cost efficiency for pharmaceutical manufacturing supply chains.
Novel 9-step route for 8-chloro-benzothiazepine-1,1-dioxide via CN111518055A. Enhances yield and scalability for RSV drug intermediates.
Patent CN101415719A details efficient L-deoxycytidine production. Offers cost reduction in antiviral manufacturing and reliable supply chain solutions.
Novel Ti-catalyzed radical cyclization for Entecavir intermediates. High purity, scalable process reducing toxic reagents. Ideal for antiviral API manufacturing.
Patent CN107207538A details a high-purity synthesis of Cenicriviroc mesylate. This report analyzes cost reduction in API manufacturing and supply chain reliability for global procurement teams.
Novel total synthesis of houttuynoid hybrid flavonoids via Pd-catalyzed coupling and oxidative cyclization, offering scalable production for antiviral drug development.
Patent CN108299445B reveals a catalyst-free thermal synthesis of 1,5-azaspiro[2,4]heptane. This method offers high purity, cis-selectivity, and reduced manufacturing costs for pharma intermediates.
Patent CN115572317A reveals a novel esterification route for Molnupiravir intermediates, offering superior purity and scalable manufacturing for global supply chains.
Novel triazole-linked betulic acid nucleoside conjugates improve solubility and antitumor activity. Scalable synthesis route available for commercial procurement.
Patent CN108779133A reveals a novel crystallization-induced dynamic resolution for Tenofovir Alafenamide, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Explore CN106795174B patent insights on diazacyclospirodiketopiperazine derivatives. Discover scalable synthesis routes for high-purity antiviral pharmaceutical intermediates.